Itacitinib Combined With INCB024360 and/or Itacitinib Combined With INCB050465 in Advanced Solid Tumors

NCT02559492 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Itacitinib
DRUG: Epacadostat
DRUG: Itacitinib
DRUG: INCB050465

Sponsor

Incyte Corporation